Conditioned medium from LS 174T goblet cells treated with oxyresveratrol strengthens tight junctions in Caco-2 cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hwang, Dahyun | - |
dc.contributor.author | Jo, HyunA | - |
dc.contributor.author | Hwang, Seonwook | - |
dc.contributor.author | Kim, Jeong-Keun | - |
dc.contributor.author | Kim, In-Ho | - |
dc.contributor.author | Lim, Young-Hee | - |
dc.date.accessioned | 2021-09-03T11:14:42Z | - |
dc.date.available | 2021-09-03T11:14:42Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2017-01 | - |
dc.identifier.issn | 0753-3322 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/84995 | - |
dc.description.abstract | Background: Strengthening of intestinal tight junctions provides an effective barrier from the external environment. Goblet cell-derived trefoil factor 3 (TFF3) increases transepithelial resistance by upregulating the expression of tight junction proteins. Oxyresveratrol (OXY) is a hydroxyl-substituted stilbene found in the roots, leaves, stems, and fruit of many plants and known to have various biological activities. In this study, we investigated the strengthening effect of OXY on intestinal tight junctions through stimulation of TFF production in goblet cells. Methods: We prepared conditioned medium from LS 174T goblet cells treated with OXY (GCO-CM) and investigated the effect of GCO-CM on strengthening tight junctions of Caco-2 cells. The mRNA and protein expression levels of major tight junction components (claudin-1, occludin, and ZO-1) were measured by quantitative real-time PCR and western blotting, respectively. Transepithelial electric resistance (TEER) was measured using an ohm/V meter. Monolayer permeability was evaluated by paracellular transport of fluorescein isothiocyanate-dextran. Results: OXY showed a strong antioxidant activity. It significantly increased the expression level of TFF3 in LS 174T goblet cells. GCO-CM prepared by treatment with 2.5, 5, and 10 mg/ml OXY did not show cytotoxicity in Caco-2 cells. GCO-CM increased the mRNA and protein expression levels of claudin-1, occludin, and ZO-1. It also significantly increased tight junction integrity and reduced permeability in a dose-dependent manner. Conclusion: OXY stimulates the expression of TFF3 in goblet cells, which might increase the integrity of the intestinal tight junction barrier. (C) 2016 Elsevier Masson SAS. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER | - |
dc.subject | INFLAMMATORY-BOWEL-DISEASE | - |
dc.subject | INTESTINAL TREFOIL FACTOR | - |
dc.subject | ANTIOXIDANT ACTIVITY | - |
dc.subject | OXIDATIVE STRESS | - |
dc.subject | BARRIER FUNCTION | - |
dc.subject | TRANSGENIC MICE | - |
dc.subject | PERMEABILITY | - |
dc.subject | EXPRESSION | - |
dc.subject | MODULATION | - |
dc.subject | PEPTIDES | - |
dc.title | Conditioned medium from LS 174T goblet cells treated with oxyresveratrol strengthens tight junctions in Caco-2 cells | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lim, Young-Hee | - |
dc.identifier.doi | 10.1016/j.biopha.2016.11.022 | - |
dc.identifier.scopusid | 2-s2.0-85007008347 | - |
dc.identifier.wosid | 000395522800033 | - |
dc.identifier.bibliographicCitation | BIOMEDICINE & PHARMACOTHERAPY, v.85, pp.280 - 286 | - |
dc.relation.isPartOf | BIOMEDICINE & PHARMACOTHERAPY | - |
dc.citation.title | BIOMEDICINE & PHARMACOTHERAPY | - |
dc.citation.volume | 85 | - |
dc.citation.startPage | 280 | - |
dc.citation.endPage | 286 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | INFLAMMATORY-BOWEL-DISEASE | - |
dc.subject.keywordPlus | INTESTINAL TREFOIL FACTOR | - |
dc.subject.keywordPlus | ANTIOXIDANT ACTIVITY | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | BARRIER FUNCTION | - |
dc.subject.keywordPlus | TRANSGENIC MICE | - |
dc.subject.keywordPlus | PERMEABILITY | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | MODULATION | - |
dc.subject.keywordPlus | PEPTIDES | - |
dc.subject.keywordAuthor | Oxyresveratrol | - |
dc.subject.keywordAuthor | TFF3 | - |
dc.subject.keywordAuthor | Tight junction | - |
dc.subject.keywordAuthor | Goblet cell | - |
dc.subject.keywordAuthor | TEER | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.